Hearing Loss Disease Portal


 
Switch to table view
Most Common: Hearing Loss (D034381), Deafness (D003638), Sensorineural HL (D006319), Waardenburg Syndrome, Usher Syndromes
Term ID:6428
Name:Liddle Syndrome
Definition:Familial pseudoaldosteronism characterized by autosomal dominant inheritance of hypertension with HYPOKALEMIA; ALKALOSIS; RENIN and ALDOSTERONE level decreases. It is caused by mutations in EPITHELIAL SODIUM CHANNELS beta and gamma subunits. Different mutations in the same EPITHELIAL SODIUM CHANNELS subunits can cause PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT.
Alternative IDs:OMIM:177200
ParentIDs:MESH:D015499
TreeNumbers:C12.777.419.815.683 |C13.351.968.419.815.683 |C16.320.565.861.698 |C18.452.648.861.698
Synonyms:Pseudoaldosteronism |Syndrome, Liddle
Slim Mappings:Genetic disease (inborn)|Metabolic disease|Urogenital disease (female)|Urogenital disease (male)
Reference: MedGen: D056929
MeSH: D056929
OMIM: 177200;

Genes: SCNN1B; SCNN1G;
Phenotypes
1 HP:0000006Autosomal dominant inheritance
2 HP:0004319Decreased circulating aldosterone level
3 HP:0003351Decreased circulating renin level
4 HP:0000822Hypertension
5 HP:0002900Hypokalemia
6 HP:0001949Hypokalemic alkalosis
7 HP:0000083Renal insufficiency
Disease Causing ClinVar Variants
Variation_NameGeneIDGeneSymbolClinicalSignificancedbSNPRCVaccessionTestedInGTRPhenotypeIDsChromosomeStartStopHGVS_cHGVS_pHGVS_gOtherIDsDisease_ClinVarDisease_hgmd
NM_000336.2(SCNN1B):c.1696C>T (p.Arg566Ter)6338SCNN1BPathogenic137852704RCV000009378; NMedGen:C0221043,OMIM:177200,ORPHA:526,SNOMED CT:71275003162339189523391895NM_000336.2:c.1696C>TNP_000327.2:p.Arg566TerNC_000016.9:g.23391895C>TOMIM Allelic Variant:600760.0001C0221043 177200 Pseudoprimary hyperaldosteronism
NM_000336.2(SCNN1B):c.1847C>T (p.Pro616Leu)6338SCNN1BPathogenic387906402RCV000009379; NMedGen:C0221043,OMIM:177200,ORPHA:526,SNOMED CT:71275003162339204623392046NM_000336.2:c.1847C>TNP_000327.2:p.Pro616LeuNC_000016.9:g.23392046C>G,NC_000016.9:g.23392046C>TOMIM Allelic Variant:600760.0002C0221043 177200 Pseudoprimary hyperaldosteronism
NM_000336.2(SCNN1B):c.1847C>G (p.Pro616Arg)6338SCNN1BPathogenic387906402RCV000009385; NMedGen:C0221043,OMIM:177200,ORPHA:526,SNOMED CT:71275003162339204623392046NM_000336.2:c.1847C>GNP_000327.2:p.Pro616ArgNC_000016.9:g.23392046C>G,NC_000016.9:g.23392046C>TOMIM Allelic Variant:600760.0008C0221043 177200 Pseudoprimary hyperaldosteronism
NM_000336.2(SCNN1B):c.1849C>T (p.Pro617Ser)6338SCNN1BPathogenic137852708RCV000009384; NMedGen:C0221043,OMIM:177200,ORPHA:526,SNOMED CT:71275003162339204823392048NM_000336.2:c.1849C>TNP_000327.2:p.Pro617SerNC_000016.9:g.23392048C>TOMIM Allelic Variant:600760.0007C0221043 177200 Pseudoprimary hyperaldosteronism
NM_000336.2(SCNN1B):c.1858T>C (p.Tyr620His)6338SCNN1BPathogenic137852707RCV000009381; NMedGen:C0221043,OMIM:177200,ORPHA:526,SNOMED CT:71275003162339205723392057NM_000336.2:c.1858T>CNP_000327.2:p.Tyr620HisNC_000016.9:g.23392057T>COMIM Allelic Variant:600760.0004C0221043 177200 Pseudoprimary hyperaldosteronism
NM_001039.3(SCNN1G):c.1718G>A (p.Trp573Ter)6340SCNN1GPathogenic137853342RCV000009372; NMedGen:C0221043,OMIM:177200,ORPHA:526,SNOMED CT:71275003162322655823226558NM_001039.3:c.1718G>ANP_001030.2:p.Trp573TerNC_000016.9:g.23226558G>AOMIM Allelic Variant:600761.0001C0221043 177200 Pseudoprimary hyperaldosteronism